Literature DB >> 18077579

Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice.

Roberto Coccurello1, Antonio Caprioli, Orlando Ghirardi, Ashraf Virmani.   

Abstract

This study deals with the possible inhibitory role played by acetyl-l-carnitine (ALC) against methamphetamine (METH)-induced behavioral sensitization. Because valproate (VAL) inhibits the behavioral sensitization exerted by different psychostimulants, we investigated ALC's potential to prevent the amplification of METH-mediated psychomotor effects. We therefore evaluated the locomotor effects of VAL or ALC alone or in combination with METH after acute (day 1) as well as repeated (day 7) drug challenge. Finally, to assess the induction of behavioral sensitization, we also recorded the METH-mediated locomotor response after 7 days of drug suspension (day 15). Results showed that both VAL and ALC prevented the METH-induced sensitization. Another interesting observation was the significantly higher METH-induced hyperactivity at day 15 (after a 7-day drug-free period), indicating that behavioral sensitization developed during the washout period. Results also showed that both the acute and repeated coadministration of METH with either VAL or ALC inhibited METH-induced hyperactivity. We present different hypotheses concerning similar but also peculiar mechanisms that might underlie the preventive action of VAL and ALC. These data add to a growing body of literature that illustrates the potential of ALC in protecting against the insult of dysfunctional mitochondrial metabolism and psychostimulant-mediated neurotoxicity. By demonstrating an in vivo action against one of the most abused drugs, these results raise the possibility of beneficial effects of ALC in abuse behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077579     DOI: 10.1196/annals.1403.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

2.  Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.

Authors:  Servio H Ramirez; Raghava Potula; Shongshan Fan; Tess Eidem; Anil Papugani; Nancy Reichenbach; Holly Dykstra; Babette B Weksler; Ignacio A Romero; Pierre O Couraud; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2009-08-05       Impact factor: 6.200

3.  Effects of sodium butyrate on methamphetamine-sensitized locomotor activity.

Authors:  John H Harkness; Robert J Hitzemann; Stephanie Edmunds; Tamara J Phillips
Journal:  Behav Brain Res       Date:  2012-11-05       Impact factor: 3.332

Review 4.  Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.

Authors:  Arthur Godino; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 5.  Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder.

Authors:  Subramaniam Jayanthi; Michael T McCoy; Jean Lud Cadet
Journal:  Genes (Basel)       Date:  2021-10-14       Impact factor: 4.096

6.  Experimental evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice.

Authors:  Yasue Horiuchi; Maya Ishikawa; Nobuko Kaito; Yoshimi Iijima; Yoshiko Tanabe; Hiroki Ishiguro; Tadao Arinami
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.